Agneta Siegbahn

Large-scale association analysis identifies new risk loci for coronary artery disease

Panos Deloukas, Stavroula Kanoni, Christina Willenborg et al. · Nature Genetics · 2012 · 1.7K citations · Full text

Medicine, Biostatistics, Cardiology +14

Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

Paolo Zanoni, Sumeet A. Khetarpal, Daniel B. Larach et al. · Science · 2016 · 547 citations · Full text

Life Sciences, Cardiology, Molecular Genetics +16

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Tomas Jernberg, Christopher D. Payne, Kenneth J. Winters et al. · European Heart Journal · 2006 · 536 citations · Full text

Medicine, Cardiology, Pharmacology +17

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

Ziad Hijazi, Jonas Oldgren, Johan Lindbäck et al. · The Lancet · 2016 · 485 citations

Medicine, Cardiology, Clinical Sciences +16

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

Lars Wallentin, Christoph Varenhorst, Stefan James et al. · European Heart Journal · 2007 · 455 citations · Full text

Medicine, Cardiology, Pharmacology +17